Sharapov, S.Z.* ; Tsepilov, Y.A.* ; Klaric, L.* ; Mangino, M.* ; Thareja, G.* ; Shadrina, A.S.* ; Simurina, M.* ; Dagostino, C.* ; Dmitrieva, J.* ; Vilaj, M.* ; Vučković, F.* ; Pavić, T.* ; Stambuk, J.* ; Trbojević-Akmačić, I.* ; Krištić, J.* ; Simunovic, J.* ; Momcilovic, A.* ; Campbell, H.* ; Doherty, M.* ; Dunlop, M.G.* ; Farrington, S.M.* ; Pučić-Baković, M.* ; Gieger, C. ; Allegri, M.* ; Louis, E.* ; Georges, M.* ; Suhre, K.* ; Spector, T.* ; Williams, F.M.K.* ; Lauc, G.* ; Aulchenko, Y.S.*
Defining the genetic control of human blood plasma N-glycome using genome-wide association study.
Hum. Mol. Genet. 28, 2062-2077 (2019)
Glycosylation is a common post-translational modification of proteins. Glycosylation is associated with a number of human diseases. Defining genetic factors altering glycosylation may provide a basis for novel approaches to diagnostic and pharmaceutical applications. Here we report a genome-wide association study of the human blood plasma N-glycome composition in up to 3811 people measured by Ultra Performance Liquid Chromatography (UPLC) technology. Starting with the 36 original traits measured by UPLC, we computed an additional 77 derived traits leading to a total of 113 glycan traits. We studied associations between these traits and genetic polymorphisms located on human autosomes. We discovered and replicated 12 loci. This allowed us to demonstrate an overlap in genetic control between total plasma protein and IgG glycosylation. The majority of revealed loci contained genes that encode enzymes directly involved in glycosylation (FUT3/FUT6, FUT8, B3GAT1, ST6GAL1, B4GALT1, ST3GAL4, MGAT3 and MGAT5) and a known regulator of plasma protein fucosylation (HNF1A). However, we also found loci that could possibly reflect other more complex aspects of glycosylation process. Functional genomic annotation suggested the role of several genes including DERL3, CHCHD10, TMEM121, IGH and IKZF1. The hypotheses we generated may serve as a starting point for further functional studies in this research area.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Immunoglobulin-g; Glycosylation; Protein; Loci; Glycans; Disease; Identification; Expression; Mechanisms; Mutations
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
0964-6906
e-ISSN
1460-2083
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 28,
Heft: 12,
Seiten: 2062-2077
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Oxford University Press
Verlagsort
Great Clarendon St, Oxford Ox2 6dp, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology (EPI)
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504091-004
Förderungen
Copyright
Erfassungsdatum
2019-06-07